权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network

一体化、个体化、智能处方（I3P）临床试验网络

基本信息

批准号：
9788502
负责人：
Joseph F. Peterson
金额：
$ 41.15万
依托单位：
VANDERBILT UNIVERSITY MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-09-19 至 2023-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9788502
关键词：
Academic Medical Centers Address Adoption Biological Assay Caring Clinical Clinical Trials Clinical Trials Network Collaborations Computerized Medical Record Conduct Clinical Trials Decision Making Development Diagnosis Diagnostic Disease Dose Ecosystem Electronic Health Record Electronic Medical Records and Genomics Network Funding General Hospitals Genetic Genetic Risk Genetic screening method Genomic medicine Genomics Genotype Health Health Personnel Health system Historically Black Colleges and Universities Hospitals Individual Infrastructure Institution Integrated Health Care Systems Intelligence Intervention Laboratories Mendelian disorder Methods Midwestern United States Outcome Participant Patients Pharmaceutical Preparations Pharmacogenomics Phenotype Population Population Heterogeneity Pragmatic clinical trial Preventive care Primary Health Care Process Provider Randomized Recommendation Research Resources Risk Signs and Symptoms Site Technology Testing Therapeutic Time Translations Uncertainty Underserved Population United States Health Resources and Services Administration United States National Institutes of Health Use Effectiveness Variant Work arm base body system clinical care clinical decision support clinical practice clinical research site cohort cost effectiveness disorder risk economic value evidence base genetic information genomic data genomic variation high risk knowledge base medical schools medically underserved novel patient population pharmacogenetic testing pragmatic trial present value programs recruit response sociodemographics tertiary care therapy outcome tool underserved rural area urban setting

项目摘要

Project Summary Using genomic variation to tailor therapeutic, preventative, and diagnostic decision-making is a potentially transformative approach to clinical care. However, uncertainty about clinical impact and economic value presents a critical barrier to broad adoption. The Integrated, Individualized, Intelligent Prescribing (I3P) Clinical Trials Network includes three clinically and sociodemographically diverse health systems to IGNITE 2: Metro General Hospital at Meharry Medical College, Sanford Health and Vanderbilt University Medical Center (VUMC). The Network will develop infrastructure to quickly recruit large, diverse patient populations, return results at the time of clinical indication, and provide health care providers with understandable, implementable guidance during the course of the trial. The first aim will develop and implement infrastructure to efficiently conduct pragmatic clinical trials involving Genomic Medicine across the diverse settings within I3P. The second aim proposes a randomized, pragmatic clinical trial of multiplexed pharmacogenomics testing across the IGNITE 2 Network to establish the clinical utility of panel testing. And finally, I3P will develop and implement an IGNITE 2 Network-wide capability to calculate Phenotype Risk Scores across health system populations to efficiently identify and intervene on patients likely to have a genomic diagnosis. All of the institutions within the I3P Network will leverage their strong record of collaboration within IGNITE 1 and other NIH funded consortia to accomplish these aims.

项目摘要使用基因组变异来调整治疗，预防和诊断决策是一个临床护理的潜在变革性方法。然而，临床影响的不确定性和经济价值是广泛采用的关键障碍。一体化、个性化、智能处方（I3P）临床试验网络包括三个临床和 IGNITE 2：Meharry的Metro综合医院医学院，桑福德健康和范德比尔特大学医学中心（VUMC）。的网络将开发基础设施，以快速招募大量不同的患者人群，结果在临床指征的时候，并提供医疗保健提供者可以理解的，在审判过程中提供指导。第一个目标将制定和实施基础设施，以有效地进行涉及基因组医学的实用临床试验， I3P中的各种设置。第二个目标是提出一个随机的、实用的临床试验 IGNITE 2网络中的多重药物基因组学测试，以建立临床面板测试的效用。最后，I3P将开发和实施IGNITE 2全网络能够计算卫生系统人群的表型风险评分，识别和干预可能有基因组诊断的患者。的所有机构在I3P网络中，将利用他们在IGNITE 1中的良好合作记录，其他NIH资助的财团来实现这些目标。